LEXARIA BIOSCIENCE CORP. Diluted Shares Outstanding (Weighted Average)
LEXARIA BIOSCIENCE CORP. (LEXX) reported Diluted Shares Outstanding (Weighted Average) of 24.81 million shares for the 3-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. weighted average number of shares outstanding, diluted for the quarter ending 2026-05-31 was 24.81M shares, a 35.56% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. weighted average number of shares outstanding, diluted for the quarter ending 2026-02-28 was 24.44M shares, a 39.58% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. weighted average number of shares outstanding, diluted for the quarter ending 2025-11-30 was 21.38M shares, a 28.24% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. weighted average number of shares outstanding, diluted for the quarter ending 2025-08-31 was 19.58M shares, a 24.60% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. weighted average number of shares outstanding, diluted for fiscal 2025 was 18.00M shares, a 45.34% increase from fiscal 2024.
- LEXARIA BIOSCIENCE CORP. weighted average number of shares outstanding, diluted for fiscal 2024 was 12.38M shares, a 87.24% increase from fiscal 2023.
- LEXARIA BIOSCIENCE CORP. weighted average number of shares outstanding, diluted for fiscal 2023 was 6.61M shares.
- LEXARIA BIOSCIENCE CORP. weighted average number of shares outstanding, diluted for fiscal 2011 was 14.18M shares, a 15.02% increase from fiscal 2010.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-05-31 | 24.81M shares 10-Q · filed 2026-07-13 | 24.62M shares derived: average of 2 quarters · filed 2026-07-13 | 23.54M shares 10-Q · filed 2026-07-13 | 22.55M shares derived: average of 4 quarters · filed 2026-07-13 |
| 2026-02-28 | 24.44M shares 10-Q · filed 2026-04-13 | 22.90M shares 10-Q · filed 2026-04-13 | 21.80M shares derived: average of 3 quarters · filed 2026-04-13 | 20.92M shares derived: average of 4 quarters · filed 2026-07-13 |
| 2025-11-30 | 21.38M shares 10-Q · filed 2026-01-13 | 20.48M shares derived: average of 2 quarters · filed 2026-01-13 | 19.75M shares derived: average of 3 quarters · filed 2026-07-13 | 19.19M shares derived: average of 4 quarters · filed 2026-07-13 |
| 2025-08-31 | 19.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | 18.94M shares derived: average of 2 quarters · filed 2026-07-13 | 18.46M shares derived: average of 3 quarters · filed 2026-07-13 | 18.00M shares 10-K · filed 2025-11-28 |
| 2025-05-31 | 18.30M shares 10-Q · filed 2026-07-13 | 17.91M shares derived: average of 2 quarters · filed 2026-07-13 | 17.47M shares 10-Q · filed 2026-07-13 | 17.05M shares derived: average of 4 quarters · filed 2026-07-13 |
| 2025-02-28 | 17.51M shares 10-Q · filed 2026-04-13 | 17.07M shares 10-Q · filed 2026-04-13 | 16.63M shares derived: average of 3 quarters · filed 2026-04-13 | 15.94M shares derived: average of 4 quarters · filed 2026-04-13 |
| 2024-11-30 | 16.67M shares 10-Q · filed 2026-01-13 | 16.19M shares derived: average of 2 quarters · filed 2026-01-13 | 15.41M shares derived: average of 3 quarters · filed 2026-01-13 | 14.25M shares derived: average of 4 quarters · filed 2026-01-13 |
| 2024-08-31 | 15.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | 14.78M shares derived: average of 2 quarters · filed 2025-11-28 | 13.44M shares derived: average of 3 quarters · filed 2025-11-28 | 12.38M shares 10-K · filed 2025-11-28 |
| 2024-05-31 | 13.86M shares 10-Q · filed 2025-07-14 | 12.31M shares derived: average of 2 quarters · filed 2025-07-14 | 11.27M shares 10-Q · filed 2025-07-14 | |
| 2024-02-29 | 10.77M shares 10-Q · filed 2025-04-14 | 9.97M shares 10-Q · filed 2025-04-14 | ||
| 2023-11-30 | 9.05M shares 10-Q · filed 2025-01-10 | |||
| 2023-08-31 | 6.61M shares 10-K · filed 2024-11-26 | |||
| 2012-07-31 | 16.44M shares 10-Q · filed 2012-09-12 | 16.43M shares derived: average of 2 quarters · filed 2012-09-12 | 16.43M shares 10-Q · filed 2012-09-12 | 16.41M shares derived: average of 4 quarters · filed 2012-09-12 |
| 2012-04-30 | 16.43M shares 10-Q · filed 2012-06-07 | 16.43M shares 10-Q · filed 2012-06-07 | 16.40M shares derived: average of 3 quarters · filed 2012-06-07 | 15.87M shares derived: average of 4 quarters · filed 2012-09-12 |
| 2012-01-31 | 16.43M shares 10-Q · filed 2012-03-13 | 16.39M shares derived: average of 2 quarters · filed 2012-03-13 | 15.69M shares derived: average of 3 quarters · filed 2012-09-12 | 15.04M shares derived: average of 4 quarters · filed 2012-09-12 |
| 2011-10-31 | 16.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | 15.31M shares derived: average of 2 quarters · filed 2012-09-12 | 14.57M shares derived: average of 3 quarters · filed 2012-09-12 | 14.18M shares 10-K · filed 2012-01-30 |
| 2011-07-31 | 14.28M shares 10-Q · filed 2012-09-12 | 13.68M shares derived: average of 2 quarters · filed 2012-09-12 | 13.45M shares 10-Q · filed 2012-09-12 | 13.30M shares derived: average of 4 quarters · filed 2012-09-12 |
| 2011-04-30 | 13.09M shares 10-Q · filed 2012-06-07 | 13.03M shares 10-Q · filed 2012-06-07 | 12.97M shares derived: average of 3 quarters · filed 2012-06-07 | 12.90M shares derived: average of 4 quarters · filed 2012-06-07 |
| 2011-01-31 | 12.98M shares 10-Q · filed 2012-03-13 | 12.92M shares derived: average of 2 quarters · filed 2012-03-13 | 12.84M shares derived: average of 3 quarters · filed 2012-03-13 | |
| 2010-10-31 | 12.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | 12.77M shares derived: average of 2 quarters · filed 2012-01-30 | 12.33M shares 10-K · filed 2012-01-30 | |
| 2010-07-31 | 12.68M shares 10-Q · filed 2011-09-14 | 12.15M shares 10-Q · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |